What Is USANA Health Sciences, Inc. (USNA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, USANA Health Sciences, Inc.'s intrinsic value is estimated at $30.48, suggesting a +117.1% median upside from the current price of $14.04. While 8 models see room for appreciation, model agreement is not unanimous as 2 models flag potential overvaluation. Model dispersion is worth noting: First Chicago targets $77.22 (+450.0%), versus ML-RIV at $1.26 (-91.0%). This +541.0% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.
What Do the Models Say About USNA?
11 of 13 models are currently active for USNA. Of these, 8 models suggest upside while 3 models suggest overvaluation. Taken together, their median fair value for USNA is $30.48 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $13.55 on its own, implying -3.5% downside from the current price. See which stocks rank higher →
How Does USNA Rank in Packaged Foods?
Among 84 Packaged Foods stocks, USNA ranks #25 by Quality of Company score. CirclFi's QOC score of 7.5/10 evaluates 32 fundamental signals. A score of 7.5 indicates above-average quality.
See all Most Undervalued Packaged Foods Stocks →
Within the Packaged Foods space, USANA Health Sciences, Inc. competes in an environment where same-store sales growth (comps) often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is USNA a Value Trap?
CirclFi's Value Trap algorithm assigns USNA a score of 45/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for USANA Health Sciences, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, USANA Health Sciences, Inc. is rated at 7.5/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.
The gap between the most bullish and bearish model spans +541.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every USNA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across USNA's 11 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →